A multicenter population-based experience with abiraterone acetate (AA) in patients with metastatic castration resistant prostate cancer (mCRPC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Clayton, Ravinder
  • Heng, Daniel Yick Chin
  • Wu, Jackson SY
  • Zielinski, Rob
  • North, Scott A
  • Emmenegger, Urban
  • Hotte, Sebastien
  • Al-Shamsi, Humaid Obaid
  • Chen, Leo
  • Eigl, Bernhard J

publication date

  • February 20, 2013